Biotechnology

At 7TM Pharma we leverage our core competencies within structure-based drug discovery and development to create a versatile, rich and sustainable pipeline of novel drugs for 7TM receptor (GPCR) targets for large therapeutic markets.
Furthermore, we engage in discovery work on other 7TM receptor targets, based on synergies with ongoing projects, therapeutic potential in other disease areas, target validation combined with the ability to apply chemistry, and high interest of potential collabor.
View Site Info: 7TM Pharma SiteInfo -»

ALK-Abelló is the world-leading producer of pharmaceuticals for specific allergy vaccination. Not only do our allergy vaccines treat the allergic symptoms, but also the underlying causes of allergy - and at the same time they prevent asthma.
ALK-Abelló has been active in allergy vaccination since 1923. In recent years, we have pursued a product development strategy of extending the current market of specialist administered subcutaneous vaccination to orally delivered alternativ.
View Site Info: ALK-Abello SiteInfo -»

Bavarian Nordic (CSE: BAVA) is a leading international biopharmaceutical company developing and producing innovative vaccines to prevent and treat infectious diseases and cancer. With operations in Denmark, Germany, the USA, and Singapore, Bavarian Nordic employs over 200 people.
Bavarian Nordic has supplied several governments with smallpox vaccines and with its increased production capacity, able to supply the growing demand, particularly for safe smallpox vaccines. With a global manufactu.
View Site Info: Bavarian Nordic SiteInfo -»

Exiqon is the global provider of Locked Nucleic Acid - LNA and a leading supplier of high-value gene expression analysis products and web-based software tools to help scientists achieve rapid and reliable results.
Our product portfolio includes our miRCURY product line for microRNA research as well as custom LNA oligonucleotides..
View Site Info: Exiqon.com SiteInfo -»

Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases.
Genmab has numerous products in development to treat cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions, and intends to continue assembling a broad portfolio of new therapeutic products. Genmab is an international company with operations in Europe and the United States..
View Site Info: Genmab SiteInfo -»

With more than 100 types of enzymes and microorganisms and not less than 700 different products Novozymes has the largest product portfolio in the world.
In more than 40 different industries and 130 countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste. Novozymes is quoted on the Copenhagen Stock Exchange..
View Site Info: Novozymes SiteInfo -»

Pedersens Laboratorium is a danish biotech company combining competencies in the areas of immunology, biochemistry, nutritional science and dermatology to develop and produce new innovative products of the highest quality. Get more information on pedlab.com.
View Site Info: Pedersens Laboratorium SiteInfo -»

TopoTarget (OMX - the Nordic Exchange: TOPO) is a biotechnology company dedicated to finding "Answers for Cancer" and developing and commercialising improved treatments of cancer and cancer-related disorders. TopoTarget was formed in 2000 in Copenhagen and is headquartered in Denmark with subsidiaries in the UK, Germany and the United States.
As of 1 June 2007 the TopoTarget group employed 120 people with expertise covering most aspects of drug development, including assay development, scree.
View Site Info: TopoTarget SiteInfo -»

Zealand Pharma is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative peptide-based products that target indications of significant unmet clinical need and commercial potential.
Zealand Pharmas specialized know-how in peptide chemistry enables the generation of novel peptide molecules with unique therapeutic qualities.
Further, to manage technical risks, the Company focuses on optimizing and developing well-understood peptides with known me.
View Site Info: Zealand Pharma SiteInfo -»